Publications by authors named "Katia Irie Teruya"

Article Synopsis
  • - Phenylketonuria (PKU) is a genetic disorder caused by the inability to metabolize phenylalanine, leading to neurotoxicity; its treatment requires a strict diet to ensure proper development in affected children.
  • - A scoping review analyzed existing research about the quality of life (QoL) of PKU patients and their caregivers, finding significant negative impacts in most studies, particularly among pediatric patients and their caregivers.
  • - Factors such as high blood phenylalanine levels, caregiver stress, and mental health issues correlated with poorer QoL, while social and emotional support acted as beneficial factors for caregivers.
View Article and Find Full Text PDF

The current cross-sectional study aimed to examine the association between childhood trauma, impulsivity, binge eating symptoms, and body mass index (BMI) in a sample of males and females. We also aimed to investigate the indirect association of childhood trauma with binge eating through impulsivity while controlling for BMI. Participants were 410 young adults (mean age = 20.

View Article and Find Full Text PDF

Neurotoxic effects caused by high phenylalanine (Phe) in patients with phenylketonuria (PKU) can be avoided through dietary treatment. However, achieving the recommended Phe levels has been a challenge. This study aimed to investigate factors associated with adherence to PKU treatment among patients followed at a medical genetics public service in southern Brazil.

View Article and Find Full Text PDF

Background: According to studies of phenylketonuria (PKU), the Brazilian population's metabolic control shows unsatisfactory indexes from childhood. Research on patients' perceived difficulties or barriers to adherence to treatment can help us to comprehend how these outcomes are associated. The present study aimed to: (1) describe the development of an inventory for identifying the most frequent and relevant perceived barriers to PKU treatment from the perspective of patients, caregivers, and healthcare professionals; (2) evaluate certain psychometric characteristics of the new measure; and, (3) explore potential predictors (sociodemographic and medical characteristics) that may contribute to increasing the number of perceived barriers and examine whether the number of barriers is associated with the degree of adherence shown by the patient.

View Article and Find Full Text PDF